Ningping Feng

9PUBLICATIONS
162CO-AUTHORS
Molecular targetsPredictive and prognostic markersMolecular medicineGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 08, 2024
Mechanisms of Resistance to Oncogenic KRAS Inhibition in Pancreatic Cancer.

Julien Dilly, Megan T Hoffman, Laleh Abbassi

|Feb 28, 2024
Ataxia-Telangiectasia Mutated Loss-of-Function Displays Variant and Tissue-Specific Differences across Tumor Types.

Patrick G PiliƩ, Virginia Giuliani, Wei-Lien Wang

|Sep 14, 2021
Phase Ib Dose Expansion and Translational Analyses of Olaparib in Combination with Capivasertib in Recurrent Endometrial, Triple-Negative Breast, and Ovarian Cancer.

Shannon N Westin, Marilyne Labrie, Jennifer K Litton

|Jun 12, 2021
Targeting Glucose Metabolism Sensitizes Pancreatic Cancer to MEK Inhibition.

Liang Yan, Bo Tu, Jun Yao

|Nov 07, 2020
Loss of ARID1A Promotes Epithelial-Mesenchymal Transition and Sensitizes Pancreatic Tumors to Proteotoxic Stress.

Hideo Tomihara, Federica Carbone, Luigi Perelli

Pageof 2